Aura Biosciences, Inc.
AURA
$6.04
-$0.06-0.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.70M | -86.92M | -83.22M | -80.69M | -78.65M |
| Total Depreciation and Amortization | 1.21M | 1.22M | 1.26M | 1.29M | 1.27M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.20M | 8.53M | 8.39M | 8.27M | 7.34M |
| Change in Net Operating Assets | 4.58M | -2.64M | 334.00K | -2.24M | -1.85M |
| Cash from Operations | -78.71M | -79.81M | -73.24M | -73.37M | -71.89M |
| Capital Expenditure | -1.35M | -1.25M | -1.27M | -1.02M | -688.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.59M | 70.07M | -49.72M | -38.23M | -37.00M |
| Cash from Investing | 89.24M | 68.82M | -50.99M | -39.25M | -37.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.44M | 1.60M | 94.04M | 94.95M | 97.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.44M | 1.60M | 94.04M | 94.95M | 97.34M |
| Foreign Exchange rate Adjustments | -21.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.95M | -9.39M | -30.20M | -17.68M | -12.23M |